SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IN_GOD_I_TRUST who wrote (203)5/8/1997 11:27:00 PM
From: harkenman   of 998
 
CEPH has no products in their pipeline. Check my posts taken from the SEC filing. Their prodcut PROVIGIL for Narcolepsy would compete againts Ritalin a major money maket for ADD. Narcoloepsy is a secondary indication. Its an orphan disease, again limited market potencial. There is someone on this thread that posted a very positive note on the merits of Provigil for ADD and that CEPH is doing research, but CEPH does not mention anything. Strange way to tout the price of a stock
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News